Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Non-Current Assets (2020 - 2023)

Historic Non-Current Assets for Cullinan Therapeutics (CGEM) over the last 4 years, with Q3 2023 value amounting to $18.0 million.

  • Cullinan Therapeutics' Non-Current Assets fell 4882.26% to $18.0 million in Q3 2023 from the same period last year, while for Sep 2023 it was $244.3 million, marking a year-over-year decrease of 2713.47%. This contributed to the annual value of $86.6 million for FY2022, which is 3838.4% down from last year.
  • Cullinan Therapeutics' Non-Current Assets amounted to $18.0 million in Q3 2023, which was down 4882.26% from $23.7 million recorded in Q2 2023.
  • Over the past 5 years, Cullinan Therapeutics' Non-Current Assets peaked at $140.6 million during Q4 2021, and registered a low of $2.4 million during Q4 2020.
  • Moreover, its 4-year median value for Non-Current Assets was $65.5 million (2022), whereas its average is $71.6 million.
  • Per our database at Business Quant, Cullinan Therapeutics' Non-Current Assets skyrocketed by 568687.24% in 2021 and then crashed by 7177.24% in 2022.
  • Cullinan Therapeutics' Non-Current Assets (Quarter) stood at $2.4 million in 2020, then skyrocketed by 5686.87% to $140.6 million in 2021, then tumbled by 38.38% to $86.6 million in 2022, then crashed by 79.23% to $18.0 million in 2023.
  • Its Non-Current Assets stands at $18.0 million for Q3 2023, versus $23.7 million for Q2 2023 and $116.0 million for Q1 2023.